Compartir
Título
Insights into the neuroprotective potential of epicatechin: effects against Aβ-Induced toxicity in caenorhabditis elegans
Autor(es)
Palabras clave
neuroprotection
flavonoids
chemotaxis
gene expression
paralysis
Fecha de publicación
2024
Editor
https://www.mdpi.com/2076-3921/13/1/79
Citación
Ayuda-Durán, B., Garzón-García, L., González-Manzano, S., Santos-Buelga, C., & González-Paramás, A. M. (2024). Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans. Antioxidants, 13(1), 79. https://doi.org/10.3390/antiox13010079
Resumen
Medical therapies to avoid the progression of Alzheimer’s disease (AD) are limited to date. Certain diets have been associated with a lower incidence of neurodegenerative diseases. In particular, the regular intake of foods rich in polyphenols, such as epicatechin (EC), could help prevent or mitigate AD progression. This work aims to explore the neuroprotective effects of EC using different transgenic strains of Caenorhabditis elegans, which express human Aβ1-42 peptides and contribute to elucidating the mechanisms involved in the effects of EC in AD. The performed assays indicate that this flavan-3-ol was able to reduce the signs of β-amyloid accumulation in C. elegans, improving motility and chemotaxis and increasing survival in transgenic strain peptide producers compared to nematodes not treated with EC. The neuroprotective effects exhibited by EC in C. elegans could be explained by the modulation of inflammation and stress-associated genes, as well as autophagy, microgliosis, and heat shock signaling pathways, involving the regulation of cpr-5, epg-8, ced-7, ZC239.12, and hsp-16 genes. Overall, the results obtained in this study support the protective effects of epicatechin against Aβ-induced toxicity.
Descripción
This research was financed by Grant PID2019-106167RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, Consejería de Educación (Project SA093P20), and Strategic Research Programs for Units of Excellence from Junta de Castilla y León (ref. CLU-2018-04). Lidia Garzón-García was financed by Grant PRE2020-095876 associated to the project MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”.
Financiadores
National Institutes of Health United States
P40 OD010440
European Social Fund Plus European Union
Consejería de Educación, Junta de Castilla y León Spain
SA093P20
URI
DOI
10.3390/ANTIOX13010079
Versión del editor
Aparece en las colecciones
Patrocinador
This research was financed by Grant PID2019-106167RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, Consejería de Educación (Project SA093P20), and Strategic Research Programs for Units of Excellence from Junta de Castilla y León (ref. CLU-2018-04). Lidia Garzón-García was financed by Grant PRE2020-095876 associated to the project MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”. Financiadores National Institutes of Health United States P40 OD010440 European Social Fund Plus European Union Consejería de Educación, Junta de Castilla y León Spain SA093P20
Files in questo item
Nombre:
Insights_Into_Neuroprotective.pdfEmbargado hasta: 2099-09-09
Tamaño:
1.266Mb
Formato:
Adobe PDF













